A randomized trial found that rizatriptan 10 mg did not significantly reduce vertigo or dizziness within 1 hour during vestibular migraine attacks, though some symptom improvements were seen at 24 hours.
In a randomized trial of nearly 500 patients, ubrogepant reduced early migraine symptoms like fatigue, neck pain, and cognitive fog when taken before headache onset.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.
A 75-year-old woman with severe weight loss and low potassium was diagnosed with pituitary Cushing’s disease, challenging assumptions about how the condition typically presents.
The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.